Company: OTSA
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061733
Chunk: 234

Company: OTSAW Ltd
Filing Date: 2025-07-07
Form: F-1/A
Chunk 234
---
     | 2023 |     |         — |     |         — |     |      187,407 |     |         — |
|             |     | 2022 |     |    35,156 |     |         — |     |            — |     |         — |
| Swisslog    |     | 2024 |     |         — |     |    47,547 |     |            — |     | 1,181,900 |
|             |     | 2023 |     |         — |     |    46,596 |     |            — |     | 1,308,032 |
|             |     | 2022 |     |         — |     |    19,733 |     |            — |     | 1,132,263 |

____________ *The amounts are classified as trade receivables and trade payables, respectively. **The amounts are total outstanding interest and principal. (Note 20 of audited financial statements) ***All related party transactions described above are denominated in USD. (1)Between financial year 2022 and 2024, Otsaw Group sold goods and services to Swisslog Healthcare AG Branch Italy, Swisslog Healthcare AG Branch Netherlands, Swisslog UK, SAS Swisslog France and Activ Technology Group. (2)Between financial year 2022 and 2024, Otsaw Group purchased goods and services from Activ Technology Pte Ltd, Serial Microelectronics Pte Ltd, Swisslog Healthcare GmbH, Swisslog Healthcare AG Branch Germany, Swisslog Healthcare AG Branch Netherlands, Meyzer Management Advisory Pte Ltd and SG Networks Pte Ltd. (3)During financial year 2022, purchase of fixed asset from Activ Technology Pte Ltd. (4)During the year 2022, the Company obtained funds from Ararrat Capital Pte. Ltd., the Immediate and Ultimate Holding Company. The loan is unsecured, bears interest at 6% per annum and repayable on demand. On April 27, 2023, the Company entered into a loan agreement with Asian Prosperity Singapore Pte . Ltd . , a Singapore corporation, in connection with working capital requirements of the Company, for a loan of S$250,000 (US$195,955) at an interest rate of 6%. The loan is repayable Ju ne 27, 2023. As of October 31, 2024 and as of the date of this prospectus, we